EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudie

Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort – A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses

Pierre André Becherel, Ziad Reguiai, Anne Claire Fougerousse, Jean Luc Perrot, Edouard Begon, Domitille Thomas-Beaulieu, Laure Mery-Bossard, Diane Pourchot, Claire Boulard, Charlotte Fite, Jessica Beaziz, Inès Zaraa und 21 weitere

Dermatology · 2024

DOI: 10.1159/000540250 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Dermatology, 2024. Verfasst von Pierre André Becherel und 32 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Clinical Immunology Unit, Antony Hospital, Antony, France. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Psoriasis, Dermatitis, Atopic, Chronic Urticaria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic inflammatory dermatoses (CIDs) can significantly affect patients’ lives. The Observatory of Chronic Inflammatory Skin Diseases (OMCCI) cohort was initiated to quantify the impact and disease evolution of four CID over 4 years’ follow-up; at least 1,000 patients per CID are planned to be enrolled. The objective of this study was to present baseline characteristics of patients included in the OMCCI cohort between December 2020 and September 2022.

Methods

This French, prospective, multicenter registry included adult patients treated in daily practice for moderate-to-severe psoriasis (PS), atopic dermatitis (AD), hidradenitis suppurativa (HS), or chronic urticaria (CU) starting or modifying a systemic treatment. At the inclusion visit and then every 6 months during 4 years, patient-reported outcomes and data on these diseases and their treatments are recorded.

Results

A total of 2,058 patients from 24 centers were included: 1,137 PS, 413 AD, 301 HS, and 207 CU. Of these, 1,950 patients started or changed systemic treatment, and 108 reduced the dose of existing systemic treatment. Disease impact was qualified as debilitating by 80.1% (PS), 90.5% (AD), 90.5% (HS), and 89.4% (CU), affecting daily, family, and professional life. According to the SF-12 Survey, the impact of all four diseases was borderline pathological for physical health and severe for mental health. At inclusion, 20.4% of patients were receiving a conventional systemic or biologic treatment. After the first visit, this percentage raised to 83.3%. During the 6 months preceding study inclusion, 17.7% (PS), 27.9% (AD), 43.1% (HS), and 43.6% (CU) of patients missed work due to their illness, and 26.3% of patients with HS had been admitted to hospital (vs. 8.1%, 5.8%, and 13% of patients with PS, AD, or CU, respectively).

Conclusion

These CIDs (especially HS) had a major impact on all aspects of patients’ quality of life. The low baseline use of systemic drugs and the high burden of these CIDs suggest that these agents are underused. Long-term and dynamic evaluation of the changes brought by the initiation or optimization of these treatments on the evolution of patients’ lives will be studied prospectively during the 4-year follow-up of the OMCCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaPsoriasisDermatitis, AtopicChronic UrticariaCost of IllnessHumansFemaleMaleAdultProspective StudiesMiddle AgedFranceQuality of LifeChronic DiseasePatient Reported Outcome Measures

Stichwörter der Autor:innen

Atopic dermatitisHidradenitis suppurativaPsoriasisQuality of lifeUrticaria

Autor:innen und Institutionen

  • Dermatology and Clinical Immunology Unit, Antony Hospital, Antony, France.
  • Department of Dermatology, Polyclinique Courlancy, Reims-Bezannes, France.
  • Hôpital d'Instruction des Armées Begin, Saint Mandé, France.
  • CHU Saint Etienne, Saint-Priest-en-Jarez, France.
  • Centre Hospitalier René Dubos, Pontoise, France.
  • Saint-Germain-en-Laye Hospital, Saint-Germain-en-Laye, France.

Zitieren

APA

Becherel, P. A., Reguiai, Z., Fougerousse, A. C., Perrot, J. L., Begon, E., Thomas-Beaulieu, D., Mery-Bossard, L., Pourchot, D., Boulard, C., Fite, C., Beaziz, J., Zaraa, I., Lons-Danic, D., Badaoui, A., Parier, J., Chaby, G., Estève, E., Liegeon, A. L., Patchinsky, A., …, & Maccari, F. (2024). Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort – A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses. Dermatology. https://doi.org/10.1159/000540250

Vancouver

Becherel PA, Reguiai Z, Fougerousse AC, Perrot JL, Begon E, Thomas-Beaulieu D, et al. Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort – A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses. Dermatology. 2024. doi:10.1159/000540250

BibTeX
@article{Becherel2024,
  author = {Becherel, Pierre André and Reguiai, Ziad and Fougerousse, Anne Claire and Perrot, Jean Luc and Begon, Edouard and Thomas-Beaulieu, Domitille and Mery-Bossard, Laure and Pourchot, Diane and Boulard, Claire and Fite, Charlotte and Beaziz, Jessica and Zaraa, Inès and Lons-Danic, Dominique and Badaoui, Antoine and Parier, Josiane and Chaby, Guillaume and Estève, Eric and Liegeon, Anne-Laure and Patchinsky, Alexandra and Muller, Philippe and Lepelley-Dupont, Charlotte and Poreaux, Claire and Jacobzone-Lévêque, Caroline and Chassain, Kevin and Mohty, Rima and Perrussel, Marc and Garcia, Charline and Girard, Céline and Dillies, Anne Sophie and Amy de la Breteque, Maud and Quiles-Tsimaratos, Nathalie and Denis, Daphné and Maccari, François},
  title = {Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort – A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000540250}
}
Kostenlos starten →